UNLABELLED: (18)F-FPPRGD2, which was approved for clinical study recently, has favorable properties for integrin targeting and showed potential for antiangiogenic therapy and early response monitoring. However, the time-consuming multiple-step synthesis may limit its widespread applications in the c...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!